查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1179495

戒菸和非尼古丁成癮產品市場：按產品、形式和分銷渠道分類：全球機會分析和行業預測，2021-2031 年

Smoking Cessation and Nicotine De-Addiction Products Market By Product, By Form, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 310 Pages | 商品交期: 2-3個工作天內

價格

預計2021年全球戒菸和脫尼古丁成癮產品市場規模將達到199.6528億美元，2031年將達到547.887億美元，2022-2031年復合年增長率為10.6%。

戒菸或尼古丁致癮是指停止使用煙草的行為。 煙草含有一種叫做尼古丁的生物鹼化合物，它會導致對香煙等吸煙裝置上癮。 這種成癮是由谷氨酸、多巴胺和γ-氨基丁酸 (GABA) 等神經遞質的釋放引起的。 此外，使用戒菸產品可以更好地治療煙草和煙草成癮者。

推動戒菸和尼古丁成癮產品市場增長的一個主要因素是，越來越多的人戒菸並發起各種政府和私人組織的戒菸活動。 此外，成人向電子煙的遷移也是市場的增長因素。 美國疾病控制與預防中心 (CDC) 報告稱，到 2021 年，60.2% 使用過煙草產品的青少年已停止使用這些產品至少一天，表示他們打算戒菸。

世界衛生組織 (WHO) 發起了承諾戒菸，這是一項為期一年的 2021 年世界無菸日全球運動，其中有 100 多個戒菸理由來紀念運動的啟動。我將其公開。 此外，免費的政府舉措、提高青年和吸煙者的意識和教育以及戒菸輔助工具的批准正在推動戒菸和尼古丁戒斷產品市場。 然而，治療劑的高成本可能會減少這些產品的購買量，從而阻礙市場增長。

市場上的主要參與者正在投資研發創新的戒菸解決方案和療法。 其中一項創新是電子香煙。 普通香煙的 90% 由煙草組成，對電子煙的需求不斷增加，電池供電的設備會產生吸入氣溶膠並且煙草含量非常低。

根據美國疾病控制和預防中心 (CDC) 的數據，煙草還與多種慢性疾病有關，包括肺癌和慢性阻塞性肺病 (COPD)。 創新尼古丁替代品進一步推動對尼古丁替代療法產品的需求，因為煙霧由 70 多種已知會導致人類癌症的化學物質和 7000 多種化學物質組成 越來越多的慢性病產業大公司推出治療產品。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析

第 4 章戒菸和尼古丁成癮產品市場：副產品

  • 概覽
    • 市場規模和預測
  • 尼古丁替代療法產品
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
    • 尼古丁替代療法產品戒菸和去尼古丁成癮產品市場，按產品類型
      • 尼古丁含片市場規模和預測：按地區
      • 尼古丁口香糖市場規模轉變和預測：按地區
      • 尼古丁噴霧劑市場規模和預測：按地區
      • 尼古丁吸入器市場規模和預測：按地區
  • 藥物治療
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 電子煙
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 5 章戒菸和去尼古丁成癮產品市場：按形式分類

  • 概覽
    • 市場規模和預測
  • 口香糖
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 吸入器
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 藥丸
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 6 章戒菸和尼古丁成癮產品市場：按分銷渠道

  • 概覽
    • 市場規模和預測
  • 醫院藥房
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 在線提供商
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 藥店和零售藥店
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 7 章戒菸和尼古丁成癮產品市場：按地區劃分

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模和預測：按產品
      • 北美尼古丁替代療法產品戒菸和去尼古丁成癮產品市場，按產品類型
    • 北美市場規模和預測：按類型
    • 北美市場規模和預測：按分銷渠道
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機會
    • 歐洲市場規模和預測：按產品
      • 歐洲尼古丁替代療法產品戒菸和去尼古丁成癮產品市場：按產品類型
    • 歐洲市場規模和預測：按類型
    • 歐洲市場規模和預測：按分銷渠道
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他歐洲
  • 亞太地區
    • 主要趨勢和機會
    • 亞太市場規模和預測：按產品
      • 亞太地區尼古丁替代療法產品戒菸和去尼古丁成癮產品市場，按產品類型
    • 亞太地區的市場規模和預測：按類型
    • 亞太市場規模和預測：按分銷渠道
    • 亞太市場規模和預測：按國家/地區分類
      • 日本
      • 中國
      • 澳大利亞
      • 印度
      • 韓國
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機會
    • LAMEA 市場規模和預測：按產品
      • LAMEA 的尼古丁替代療法產品戒菸和去尼古丁成癮產品市場：按產品類型
    • LAMEA 市場規模和預測：按類型
    • LAMEA 市場規模和預測：按分銷渠道
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其餘部分

第八章公司情況

  • 簡介
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第九章公司簡介

  • British American Tobacco Plc
  • 22nd Century group Inc.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline Plc.
  • Imperial Brands Plc.
  • Johnson and Johnson Inc
  • Njoy Company
  • Perrigo Company Plc.
  • Pfizer Inc.
  • Zydus Cadila, Inc.
  • Rusan Pharma Ltd
Product Code: A00370

The global smoking cessation and nicotine de-addiction products market was valued at $19,965.28million in 2021, and is estimated to reach $54,708.87 million by 2031, growing at a CAGR of 10.6% from 2022 to 2031.

Smoking cessation or nicotine de-addiction means the act of stopping tobacco use. Tobacco contains alkaloid compound called nicotine, which causes addiction toward cigarettes and other smoking products. The addiction is caused by releasing neurotransmitters such as glutamate, dopamine, and gamma-aminobutyric acid (GABA). Furthermore, cigarette and tobacco addicts can be better treated with smoking cessation products.

Major factors that drive growth of the smoking cessation and nicotine de-addiction products market is the rise in number of populations who are quitting smoking and ant-smoking initiatives and campaigns by various governments and private organizations . Furthermore, shift of adults toward e-cigarettes also serves as a growing factor for the market. The Centers for Disease Control and Prevention (CDC) stated that, 60.2% of youth who used tobacco products have stopped using all these products for one day or longer as they were willing to quit tobacco in 2021.

The World Health Organization (WHO) launched a year-long global campaign for World No Tobacco Day 2021, "Commit to Quit" challenge and published more than 100 reasons to quit tobacco to mark start of the campaign. In addition, free initiatives by governments, increase in consciousness and education among young population and smokers, and approved smoking cessation drugs in the market are leveraging smoking cessation and nicotine de-addiction products market. However, high cost of therapies can lead to decrease in purchase of these products, which can ultimately hinder growth of the market.

Key market players are investing in research and development of innovative solutions and therapies for smoking cessation. One such innovation is e-cigarettes. Normal cigarettes consist 90% tobacco, which is increasing demand of e-cigarette that is a battery-powered device that generates an inhaled aerosol and have very less tobacco.

According to the Centers for Disease Control and Prevention (CDC), cigarette smoking also causes various chronic disease such as lung cancer and chronic obstructive pulmonary disease (COPD). As smoke consists of over 7000 chemicals, with over 70 chemicals known to cause cancer in humans, rise in number of chronic ailments propel major companies to introduce innovative nicotine replacement therapy products further driving demand for nicotine replacement therapy products.

The global smoking cessation and nicotine de-addiction products market is segmented on the basis of product, form, distribution channel, and region. On the basis of product, the market is categorized into nicotine replacement therapy products, drug therapy, and e-cigarettes. The nicotine replacement therapy segment is further divided into nicotine lozenges, nicotine gums, nicotine sprays, and nicotine inhalers. By form, the market is divided into gum, inhalers, tablets, and others. By distribution channel, it is segmented into hospital pharmacies, online providers, and drug stores and retail pharmacies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).

Major players profiled in the report are British American Tobacco Inc., 22nd Century group Inc., Cipla Ltd., Dr. Reddy's Laboratories Ltd, GlaxoSmithKline PLC (Haleon), Imperial Brands Plc. (Fontem Ventures), Johnson and Johnson (McNeil Consumer Health), Njoy Company, Pfizer Inc., Perrigo Company Plc., Rusan Pharma, and Zydus Cadila.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the smoking cessation and nicotine de-addiction products market analysis from 2021 to 2031 to identify the prevailing smoking cessation and nicotine de-addiction products market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the smoking cessation and nicotine de-addiction products market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global smoking cessation and nicotine de-addiction products market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Nicotine Replacement Therapy Products
    • Type
    • Nicotine Lozenges
    • Nicotine Gums
    • Nicotine Sprays
    • Nicotine Inhalers
  • Drug Therapy
  • E-cigarettes

By Form

  • Gum
  • Inhaler
  • Tablet
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Online Provider
  • Drug stores and Retail Pharmacies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • British American Tobacco Plc
    • 22nd Century group Inc.
    • Cipla Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline Plc.
    • Imperial Brands Plc.
    • Johnson and Johnson Inc
    • Njoy Company
    • Perrigo Company Plc.
    • Pfizer Inc.
    • Zydus Cadila, Inc.
    • Rusan Pharma Ltd

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Nicotine Replacement Therapy Products
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
      • 4.2.4.1 Nicotine Lozenges Market size and forecast, by region
      • 4.2.4.2 Nicotine Gums Market size and forecast, by region
      • 4.2.4.3 Nicotine Sprays Market size and forecast, by region
      • 4.2.4.4 Nicotine Inhalers Market size and forecast, by region
  • 4.3 Drug Therapy
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 E-cigarettes
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country

CHAPTER 5: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Gum
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Inhaler
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Tablet
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Others
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospital Pharmacies
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Online Provider
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Drug stores and Retail Pharmacies
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
      • 7.2.2.1 North America Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
    • 7.2.3 North America Market size and forecast, by Form
    • 7.2.4 North America Market size and forecast, by Distribution Channel
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Product
      • 7.2.5.1.2 Market size and forecast, by Form
      • 7.2.5.1.3 Market size and forecast, by Distribution Channel
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Product
      • 7.2.5.2.2 Market size and forecast, by Form
      • 7.2.5.2.3 Market size and forecast, by Distribution Channel
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Product
      • 7.2.5.3.2 Market size and forecast, by Form
      • 7.2.5.3.3 Market size and forecast, by Distribution Channel
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
      • 7.3.2.1 Europe Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
    • 7.3.3 Europe Market size and forecast, by Form
    • 7.3.4 Europe Market size and forecast, by Distribution Channel
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Product
      • 7.3.5.1.2 Market size and forecast, by Form
      • 7.3.5.1.3 Market size and forecast, by Distribution Channel
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Product
      • 7.3.5.2.2 Market size and forecast, by Form
      • 7.3.5.2.3 Market size and forecast, by Distribution Channel
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Product
      • 7.3.5.3.2 Market size and forecast, by Form
      • 7.3.5.3.3 Market size and forecast, by Distribution Channel
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Product
      • 7.3.5.4.2 Market size and forecast, by Form
      • 7.3.5.4.3 Market size and forecast, by Distribution Channel
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Product
      • 7.3.5.5.2 Market size and forecast, by Form
      • 7.3.5.5.3 Market size and forecast, by Distribution Channel
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Product
      • 7.3.5.6.2 Market size and forecast, by Form
      • 7.3.5.6.3 Market size and forecast, by Distribution Channel
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
      • 7.4.2.1 Asia-Pacific Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Form
    • 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Product
      • 7.4.5.1.2 Market size and forecast, by Form
      • 7.4.5.1.3 Market size and forecast, by Distribution Channel
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Product
      • 7.4.5.2.2 Market size and forecast, by Form
      • 7.4.5.2.3 Market size and forecast, by Distribution Channel
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Market size and forecast, by Product
      • 7.4.5.3.2 Market size and forecast, by Form
      • 7.4.5.3.3 Market size and forecast, by Distribution Channel
      • 7.4.5.4 India
      • 7.4.5.4.1 Market size and forecast, by Product
      • 7.4.5.4.2 Market size and forecast, by Form
      • 7.4.5.4.3 Market size and forecast, by Distribution Channel
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Product
      • 7.4.5.5.2 Market size and forecast, by Form
      • 7.4.5.5.3 Market size and forecast, by Distribution Channel
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Market size and forecast, by Product
      • 7.4.5.6.2 Market size and forecast, by Form
      • 7.4.5.6.3 Market size and forecast, by Distribution Channel
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
      • 7.5.2.1 LAMEA Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
    • 7.5.3 LAMEA Market size and forecast, by Form
    • 7.5.4 LAMEA Market size and forecast, by Distribution Channel
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Product
      • 7.5.5.1.2 Market size and forecast, by Form
      • 7.5.5.1.3 Market size and forecast, by Distribution Channel
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Product
      • 7.5.5.2.2 Market size and forecast, by Form
      • 7.5.5.2.3 Market size and forecast, by Distribution Channel
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Product
      • 7.5.5.3.2 Market size and forecast, by Form
      • 7.5.5.3.3 Market size and forecast, by Distribution Channel
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Product
      • 7.5.5.4.2 Market size and forecast, by Form
      • 7.5.5.4.3 Market size and forecast, by Distribution Channel

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 British American Tobacco Plc
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 22nd Century group Inc.
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Cipla Ltd.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Dr. Reddy's Laboratories Ltd.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 GlaxoSmithKline Plc.
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Imperial Brands Plc.
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Johnson and Johnson Inc
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Njoy Company
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Perrigo Company Plc.
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Pfizer Inc.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
  • 9.11 Zydus Cadila, Inc.
    • 9.11.1 Company overview
    • 9.11.2 Company snapshot
    • 9.11.3 Operating business segments
    • 9.11.4 Product portfolio
    • 9.11.5 Business performance
    • 9.11.6 Key strategic moves and developments
  • 9.12 Rusan Pharma Ltd
    • 9.12.1 Company overview
    • 9.12.2 Company snapshot
    • 9.12.3 Operating business segments
    • 9.12.4 Product portfolio
    • 9.12.5 Business performance
    • 9.12.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 2. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE REPLACEMENT THERAPY PRODUCTS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR NICOTINE REPLACEMENT THERAPY PRODUCTS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 5. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE LOZENGES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 6. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE GUMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE SPRAYS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE INHALERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR DRUG THERAPY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR DRUG THERAPY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR E-CIGARETTES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR E-CIGARETTES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 14. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR GUM, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR GUM, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR INHALER, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR INHALER, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 18. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR TABLET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR TABLET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 23. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR ONLINE PROVIDER, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR ONLINE PROVIDER, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 28. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 29. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 30. NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 31. NORTH AMERICA NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 32. NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 33. NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 34. NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 35. U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 36. U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 37. U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 38. CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 39. CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 40. CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 41. MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 42. MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 43. MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 44. EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 45. EUROPE NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 46. EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 47. EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 48. EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 49. GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 50. GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 51. GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 52. FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 53. FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 54. FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 55. UK SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 56. UK SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 57. UK SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 58. ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 59. ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 60. ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 61. SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 62. SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 63. SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 64. REST OF EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 65. REST OF EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 66. REST OF EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 68. ASIA-PACIFIC NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 69. ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 70. ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 71. ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 72. JAPAN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 73. JAPAN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 74. JAPAN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 75. CHINA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 76. CHINA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 77. CHINA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 79. AUSTRALIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 80. AUSTRALIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 81. INDIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 82. INDIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 83. INDIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 84. SOUTH KOREA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 85. SOUTH KOREA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 86. SOUTH KOREA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 87. REST OF ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 90. LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 91. LAMEA NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 92. LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 93. LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 94. LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 95. BRAZIL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 96. BRAZIL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 97. BRAZIL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 98. SAUDI ARABIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 99. SAUDI ARABIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 100. SAUDI ARABIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 101. SOUTH AFRICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 102. SOUTH AFRICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 103. SOUTH AFRICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 104. REST OF LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 105. REST OF LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 106. REST OF LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 107.BRITISH AMERICAN TOBACCO PLC: COMPANY SNAPSHOT
  • TABLE 108.BRITISH AMERICAN TOBACCO PLC: OPERATING SEGMENTS
  • TABLE 109.BRITISH AMERICAN TOBACCO PLC: PRODUCT PORTFOLIO
  • TABLE 110.BRITISH AMERICAN TOBACCO PLC: NET SALES,
  • TABLE 111.BRITISH AMERICAN TOBACCO PLC: KEY STRATERGIES
  • TABLE 112.22ND CENTURY GROUP INC.: COMPANY SNAPSHOT
  • TABLE 113.22ND CENTURY GROUP INC.: OPERATING SEGMENTS
  • TABLE 114.22ND CENTURY GROUP INC.: PRODUCT PORTFOLIO
  • TABLE 115.22ND CENTURY GROUP INC.: NET SALES,
  • TABLE 116.22ND CENTURY GROUP INC.: KEY STRATERGIES
  • TABLE 117.CIPLA LTD.: COMPANY SNAPSHOT
  • TABLE 118.CIPLA LTD.: OPERATING SEGMENTS
  • TABLE 119.CIPLA LTD.: PRODUCT PORTFOLIO
  • TABLE 120.CIPLA LTD.: NET SALES,
  • TABLE 121.CIPLA LTD.: KEY STRATERGIES
  • TABLE 122.DR. REDDY'S LABORATORIES LTD.: COMPANY SNAPSHOT
  • TABLE 123.DR. REDDY'S LABORATORIES LTD.: OPERATING SEGMENTS
  • TABLE 124.DR. REDDY'S LABORATORIES LTD.: PRODUCT PORTFOLIO
  • TABLE 125.DR. REDDY'S LABORATORIES LTD.: NET SALES,
  • TABLE 126.DR. REDDY'S LABORATORIES LTD.: KEY STRATERGIES
  • TABLE 127.GLAXOSMITHKLINE PLC.: COMPANY SNAPSHOT
  • TABLE 128.GLAXOSMITHKLINE PLC.: OPERATING SEGMENTS
  • TABLE 129.GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
  • TABLE 130.GLAXOSMITHKLINE PLC.: NET SALES,
  • TABLE 131.GLAXOSMITHKLINE PLC.: KEY STRATERGIES
  • TABLE 132.IMPERIAL BRANDS PLC.: COMPANY SNAPSHOT
  • TABLE 133.IMPERIAL BRANDS PLC.: OPERATING SEGMENTS
  • TABLE 134.IMPERIAL BRANDS PLC.: PRODUCT PORTFOLIO
  • TABLE 135.IMPERIAL BRANDS PLC.: NET SALES,
  • TABLE 136.IMPERIAL BRANDS PLC.: KEY STRATERGIES
  • TABLE 137.JOHNSON AND JOHNSON INC: COMPANY SNAPSHOT
  • TABLE 138.JOHNSON AND JOHNSON INC: OPERATING SEGMENTS
  • TABLE 139.JOHNSON AND JOHNSON INC: PRODUCT PORTFOLIO
  • TABLE 140.JOHNSON AND JOHNSON INC: NET SALES,
  • TABLE 141.JOHNSON AND JOHNSON INC: KEY STRATERGIES
  • TABLE 142.NJOY COMPANY: COMPANY SNAPSHOT
  • TABLE 143.NJOY COMPANY: OPERATING SEGMENTS
  • TABLE 144.NJOY COMPANY: PRODUCT PORTFOLIO
  • TABLE 145.NJOY COMPANY: NET SALES,
  • TABLE 146.NJOY COMPANY: KEY STRATERGIES
  • TABLE 147.PERRIGO COMPANY PLC.: COMPANY SNAPSHOT
  • TABLE 148.PERRIGO COMPANY PLC.: OPERATING SEGMENTS
  • TABLE 149.PERRIGO COMPANY PLC.: PRODUCT PORTFOLIO
  • TABLE 150.PERRIGO COMPANY PLC.: NET SALES,
  • TABLE 151.PERRIGO COMPANY PLC.: KEY STRATERGIES
  • TABLE 152.PFIZER INC.: COMPANY SNAPSHOT
  • TABLE 153.PFIZER INC.: OPERATING SEGMENTS
  • TABLE 154.PFIZER INC.: PRODUCT PORTFOLIO
  • TABLE 155.PFIZER INC.: NET SALES,
  • TABLE 156.PFIZER INC.: KEY STRATERGIES
  • TABLE 157.ZYDUS CADILA, INC.: COMPANY SNAPSHOT
  • TABLE 158.ZYDUS CADILA, INC.: OPERATING SEGMENTS
  • TABLE 159.ZYDUS CADILA, INC.: PRODUCT PORTFOLIO
  • TABLE 160.ZYDUS CADILA, INC.: NET SALES,
  • TABLE 161.ZYDUS CADILA, INC.: KEY STRATERGIES
  • TABLE 162.RUSAN PHARMA LTD: COMPANY SNAPSHOT
  • TABLE 163.RUSAN PHARMA LTD: OPERATING SEGMENTS
  • TABLE 164.RUSAN PHARMA LTD: PRODUCT PORTFOLIO
  • TABLE 165.RUSAN PHARMA LTD: NET SALES,
  • TABLE 166.RUSAN PHARMA LTD: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET SEGMENTATION
  • FIGURE 2.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031
  • FIGURE 3.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,BY PRODUCT,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DRUG THERAPY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF E-CIGARETTES SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
  • FIGURE 16.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,BY FORM,2021(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF GUM SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF INHALER SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF TABLET SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
  • FIGURE 21.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,BY DISTRIBUTION CHANNEL,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HOSPITAL PHARMACIES SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ONLINE PROVIDER SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF DRUG STORES AND RETAIL PHARMACIES SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
  • FIGURE 25.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET BY REGION,2021
  • FIGURE 26.U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 27.CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 28.MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 29.GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 30.FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 31.UK SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 32.ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 33.SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 34.REST OF EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 35.JAPAN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 36.CHINA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 37.AUSTRALIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 38.INDIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 39.SOUTH KOREA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 41.BRAZIL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 42.SAUDI ARABIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 43.SOUTH AFRICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 44.REST OF LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49.COMPETITIVE DASHBOARD
  • FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 51.BRITISH AMERICAN TOBACCO PLC.: NET SALES ,($MILLION)
  • FIGURE 52.22ND CENTURY GROUP INC..: NET SALES ,($MILLION)
  • FIGURE 53.CIPLA LTD..: NET SALES ,($MILLION)
  • FIGURE 54.DR. REDDY'S LABORATORIES LTD..: NET SALES ,($MILLION)
  • FIGURE 55.GLAXOSMITHKLINE PLC..: NET SALES ,($MILLION)
  • FIGURE 56.IMPERIAL BRANDS PLC..: NET SALES ,($MILLION)
  • FIGURE 57.JOHNSON AND JOHNSON INC.: NET SALES ,($MILLION)
  • FIGURE 58.NJOY COMPANY.: NET SALES ,($MILLION)
  • FIGURE 59.PERRIGO COMPANY PLC..: NET SALES ,($MILLION)
  • FIGURE 60.PFIZER INC..: NET SALES ,($MILLION)
  • FIGURE 61.ZYDUS CADILA, INC..: NET SALES ,($MILLION)
  • FIGURE 62.RUSAN PHARMA LTD.: NET SALES ,($MILLION)